126 related articles for article (PubMed ID: 101067)
21. Protection of ischemic myocardium by nitroglycerin: experimental and clinical results.
Epstein SE; Borer JS; Kent KM; Redwood DR; Goldstein RE; Levitt B
Circulation; 1976 Mar; 53(3 Suppl):I191-8. PubMed ID: 815059
[TBL] [Abstract][Full Text] [Related]
22. Effect of nitroglycerin and dipyridamole on regional left ventricular blood flow during coronary artery occlusion.
Becker LC
J Clin Invest; 1976 Dec; 58(6):1287-96. PubMed ID: 825534
[TBL] [Abstract][Full Text] [Related]
23. Effect of propranolol on enzymatic and histochemical estimates of infarct size in experimental myocardial infarction.
Jesmok GJ; Warltier DC; Gross GJ; Hardman HF
Basic Res Cardiol; 1978; 73(6):559-70. PubMed ID: 747615
[TBL] [Abstract][Full Text] [Related]
24. Acute coronary occlusion in the pig: effect of nitroglycerin on regional myocardial blood flow.
Most AS; Williams DO; Millard RW
Am J Cardiol; 1978 Dec; 42(6):947-53. PubMed ID: 103419
[TBL] [Abstract][Full Text] [Related]
25. Ischemic changes in the canine heart as affected by the dimethyl quaternary analog of propranolol, UM-272 (SC-27761).
Lucchesi BR; Burmeister WE; Lomas TE; Abrams GD
J Pharmacol Exp Ther; 1976 Nov; 199(2):310-28. PubMed ID: 978488
[TBL] [Abstract][Full Text] [Related]
26. The effect of hypoglycemia on myocardial ischemic injury during acute experimental coronary artery occlusion.
Libby P; Maroko PR; Braunwald E
Circulation; 1975 Apr; 51(4):621-6. PubMed ID: 1116252
[TBL] [Abstract][Full Text] [Related]
27. Effects of dimethyl propranolol (UM-272; SC-27761) on myocardial ischemic injury in the canine heart after temporary coronary artery occlusion.
KU DD; Lucchesi BR
Circulation; 1978 Mar; 57(3):541-8. PubMed ID: 624163
[TBL] [Abstract][Full Text] [Related]
28. Nitroglycerin and heterogeneity of myocardial blood flow. Reduced subendocardial blood flow and ventricular contractile force.
Forman R; Kirk ES; Downey JM; Sonnenblick EH
J Clin Invest; 1973 Apr; 52(4):905-11. PubMed ID: 4632692
[TBL] [Abstract][Full Text] [Related]
29. Absence of a lateral border zone of intermediate creatine phosphokinase depletion surrounding a central infarct 24 hours after acute coronary occlusion in the dog.
Hirzel HO; Sonnenblick EH; Kirk ES
Circ Res; 1977 Nov; 41(5):673-83. PubMed ID: 908113
[TBL] [Abstract][Full Text] [Related]
30. Reduction by cobra venom factor of myocardial necrosis after coronary artery occlusion.
Maroko PR; Carpenter CB; Chiariello M; Fishbein MC; Radvany P; Knostman JD; Hale SL
J Clin Invest; 1978 Mar; 61(3):661-70. PubMed ID: 641147
[TBL] [Abstract][Full Text] [Related]
31. Assessment of the efficacy of interventions to limit ischemic injury by direct measurement of intramural carbon dioxide tension after coronary artery occlusion in the dog.
Hillis LD; Khuri SF; Braunwald E; Kloner RA; Tow D; Barsamian E; Maroko PR
J Clin Invest; 1979 Jan; 63(1):99-107. PubMed ID: 105016
[TBL] [Abstract][Full Text] [Related]
32. Vasodilator synchronized retroperfusion: quantitative assessment of flow-function relation in acutely ischemic canine myocardium.
Berdeaux A; Farcot JC; Giudicelli JF; Bourdarias JP
Am J Cardiol; 1985 May; 55(11):1417-22. PubMed ID: 3922210
[TBL] [Abstract][Full Text] [Related]
33. Nitroglycerin in experimental myocardial infarction. Effects on regional left ventricular length and tension.
Banka VS; Bodenheimer MM; Helfant RH
Am J Cardiol; 1975 Oct; 36(4):453-8. PubMed ID: 811106
[TBL] [Abstract][Full Text] [Related]
34. Intracoronary administration of the alpha 1-receptor agonist, methoxamine, does not reproduce the infarct-limiting effect of ischemic preconditioning in dogs.
Sebbag L; Katsuragawa M; Verbinski S; Jennings RB; Reimer KA
Cardiovasc Res; 1996 Nov; 32(5):830-8. PubMed ID: 8944813
[TBL] [Abstract][Full Text] [Related]
35. Failure of high doses of propranolol to reduce experimental myocardial ischemic damage.
Peter T; Heng MK; Singh BN; Ambler P; Nisbet H; Elliot R; Norris RM
Circulation; 1978 Mar; 57(3):534-40. PubMed ID: 624162
[TBL] [Abstract][Full Text] [Related]
36. Transmural triglycerides in acute myocardial ischaemia.
Jesmok GJ; Warltier DC; Gross GJ; Hardman HF
Cardiovasc Res; 1978 Nov; 12(11):659-65. PubMed ID: 750079
[TBL] [Abstract][Full Text] [Related]
37. Comparative effects of nitroglycerin and nifedipine on myocardial blood flow and contraction during flow-limiting coronary stenosis in the dog.
Weintraub WS; Akizuki S; Agarwal JB; Bodenheimer MM; Banka VS; Helfant RH
Am J Cardiol; 1982 Aug; 50(2):281-8. PubMed ID: 6808819
[TBL] [Abstract][Full Text] [Related]
38. Effects of nitroglycerin on transmural myocardial blood flow in the unanesthetized dog.
Bache RJ; Ball RM; Cobb FR; Rembert JC; Greenfield JC
J Clin Invest; 1975 Jun; 55(6):1219-28. PubMed ID: 805796
[TBL] [Abstract][Full Text] [Related]
39. Regional Myocardial function in the conscious dog during acute coronary occlusion and responses to morphine, propranolol, nitroglycerin, and lidocaine.
Theroux P; Ross J; Franklin D; Kemper WS; Sasyama S
Circulation; 1976 Feb; 53(2):302-14. PubMed ID: 812613
[TBL] [Abstract][Full Text] [Related]
40. Improvement in ischemic myocardial blood flow following a new calcium antagonist.
Jolly SR; Gross GJ
Am J Physiol; 1980 Aug; 239(2):H163-71. PubMed ID: 6773426
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
